Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Jenny N Poynter, PhD, Michaela Richardson, Erica Langer, Anthony Hooten, Michelle A. Roesler, BS, Betsy A. Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Erica Warlick, MD, Julie A Ross, PhD

Blood (2015) 126 (23): 2885.

https://doi.org/10.1182/blood.V126.23.2885.2885

Published: 2015

Journal Articles

Variants in PVT1 are Associated with Susceptibility for Hodgkin Lymphoma in Children and Adolescents: A Children’s Oncology Group Study

Amy Linabery, PhDMS, Seymour Grufferman, MD DrPH, Jenny N. Poynter, PhD, Julie A. Ross, PhD, Logan G. Spector, PhD, Kara M. Kelly, MD, William Iacono, PhD, Matthew McGue, PhD, Nathan Pankratz, PhD

Blood (2014) 124 (21): 2950.

https://doi.org/10.1182/blood.V124.21.2950.2950

Published: 2014

Journal Articles

Mutant tp53 Causes a Gain of Function Increase in Sensitivity to Reactive Oxygen Species in Erythroid Precursors

Troy C. Lund, MDPhD, Michelle L Carter, PhD, Ashley C. Kramer, Bruce R. Blazar, MD, Julie A. Ross, PhD

Blood (2014) 124 (21): 2668.

https://doi.org/10.1182/blood.V124.21.2668.2668

Published: 2014

Journal Articles

Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT)

Julie A. Ross, PhD, Jakub Tolar, MD PhD, Logan G. Spector, PhD, Todd E. Defor, MS, Troy C. Lund, MDPhD, Daniel J. Weisdorf, MD, Anthony J. Hooten, B.S., Bharat Thyagarajan, MD PhD, Erica Langer, BS, Michelle K. Gleason, PhD, John E Wagner, MD, Kimberly Robien, PhD RD, Michael R. Verneris, MD

Blood (2014) 124 (21): 683.

https://doi.org/10.1182/blood.V124.21.683.683

Published: 2014

Journal Articles

Infants with Leukemia Exhibit Compound Heterozygosity for Deleterious Germline Variation in MLL3 Independent of MLL-Rearrangements

Mark C Valentine, BS, Elizabeth L Ostrander, BS, Amy Linabery, PhDMS, Logan G. Spector, PhD, Julie A. Ross, PhD, Todd E Druley, MDPhD

Blood (2014) 124 (21): 485.

https://doi.org/10.1182/blood.V124.21.485.485

Published: 2014

Journal Articles

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Michelle K. Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen Spellman, Michael D. Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling-Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller

Blood (2014) 123 (19): 3016–3026.

https://doi.org/10.1182/blood-2013-10-533398

Published: 2014

Includes: Supplemental data

Journal Articles

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Angela R. Smith, MD, MS, Erica D. Warlick, MD, Rachel K. Fonstad, M.S., Michelle A. Roesler, Jenny N. Poynter, PhD, Betsy Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Julie A Ross, PhD

Blood (2013) 122 (21): 1541.

https://doi.org/10.1182/blood.V122.21.1541.1541

Published: 2013

Journal Articles

KIR Gene Repertoire and Hodgkin Lymphoma In Children and Adolescents: A Children’s Oncology Group Study

Amy M. Linabery, PhD, MS, Seymour Grufferman, MD, DrPH, Jacquelyn Kuriger, MS, Julie A Ross, PhD, Logan G. Spector, PhD, Heather H. Nelson, PhD

Blood (2013) 122 (21): 4235.

https://doi.org/10.1182/blood.V122.21.4235.4235

Published: 2013

Journal Articles

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Daniel Pease, MD, Julie A Ross, PhD, Phuong L. Nguyen, MD, Betsy Hirsch, PhD, Adina Cioc, MD, Angela R. Smith, MD, MS, Michelle A. Roesler, Rachel K. Fonstad, M.S., Erica D. Warlick, MD

Blood (2013) 122 (21): 2798.

https://doi.org/10.1182/blood.V122.21.2798.2798

Published: 2013

Journal Articles

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Julie A Ross, PhD, Todd E Druley, MD, PhD, Kimberly J Johnson, Rachel K. Fonstad, M.S., Julie von Behren, MPH, Beth Mueller, PhD, Susan Carozza, PhD, Eric J. Chow, MD, MPH, Colleen McLaughlin, PhD, Peggy Reynolds, PhD, Erin Fox, PhD, Scott Horel, Logan G. Spector, PhD

Blood (2013) 122 (21): 1395.

https://doi.org/10.1182/blood.V122.21.1395.1395

Published: 2013

Journal Articles

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Erica D. Warlick, MD, Phuong L. Nguyen, MD, Rachel K. Fonstad, M.S., Adina Cioc, MD, Betsy Hirsch, PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Michelle A. Roesler, Julie A Ross, PhD

Blood (2013) 122 (21): 1546.

https://doi.org/10.1182/blood.V122.21.1546.1546

Published: 2013

Journal Articles

Germline Exome Sequencing From MLL -Negative Infant AML Patients Reveals Compound Heterozygosity For Novel, Non-Synonymous Alleles Of MLL3 : A Report From The Children’s Oncology Group (COG)

Mark C. Valentine, Amy M. Linabery, PhD, MS, Logan G. Spector, PhD, Julie A Ross, PhD, Todd E Druley, MD, PhD

Blood (2013) 122 (21): 62.

https://doi.org/10.1182/blood.V122.21.62.62

Published: 2013

Journal Articles

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Michelle K. Gleason, PhD, Julie A. Ross, PhD, Troy C. Lund, MD/PhD, Michael R. Verneris, MD, Andres Wiernik, MD, Erica D. Warlick, MD, Stephen Spellman, MBS, Michael D. Haagenson, MS, Alexander J. Lenvik, Mark R. Litzow, MD, Daniel J. Weisdorf, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD

Blood (2013) 122 (21): 385.

https://doi.org/10.1182/blood.V122.21.385.385

Published: 2013

Journal Articles

Comparison of IPSS and IPSS-R Scoring in a Population Based Myelodysplastic Syndromes (MDS) Study

Erica D. Warlick, MD, Betsy A. Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, Michelle A. Roesler, Rachel Fonstad, M.S., Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Julie A. Ross, PhD

Blood (2012) 120 (21): 3841.

https://doi.org/10.1182/blood.V120.21.3841.3841

Published: 2012

Journal Articles

Bi-Specific Killer Cell Engagers (BiKEs) Signaling Through CD16 and Targeting CD33 (CD16 × CD33), Triggers Natural Killer (NK) Cell Cytotoxic and Cytokine Production Against Refractory Acute Myeloid Leukemia (AML)

Andres Wiernik, MD, Bree Foley, PhD, Bin Zhang, Michael R. Verneris, MD, Erica Warlick, MD, Julie A. Ross, PhD, Louis M. Weiner, MD, Daniel J. Weisdorf, MD, Daniel A Vallera, PhD, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 256.

https://doi.org/10.1182/blood.V120.21.256.256

Published: 2012

Journal Articles

Matched Exome Sequencing in Mothers and Infants with MLL-Negative Acute Leukemia

Todd E. Druley, MD, PhD, Mark Valentine, Nicholas Sanchez, Julie A. Ross, PhD

Blood (2012) 120 (21): 536.

https://doi.org/10.1182/blood.V120.21.536.536

Published: 2012

Journal Articles

Initial Clinical Findings From a Population-Based Study of Adult Myelodysplastic Syndrome: Discordance Between World Health Organization (WHO) Classifications

Erica D Warlick, MD, Phuong L. Nguyen, MD, Adina Cioc, Betsy A. Hirsch, PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Michelle A. Roesler, Jessica Musselman, Julie A. Ross, PhD

Blood (2011) 118 (21): 1733.

https://doi.org/10.1182/blood.V118.21.1733.1733

Published: 2011

Journal Articles

Genetic Susceptibility Loci and Risk of Infant Leukemia by Subtype and MLL status: A Children's Oncology Group Report

Julie A. Ross, PhD, Amy M. Linabery, PhD, Crystal Blommer, BS, Erica Langer, BS, Logan G. Spector, PhD, Joanne M. Hilden, MD, Nyla A. Heerema, PhD, Richard L. Tower, II, MD, MS, Stella M. Davies, MBBS, PhD

Blood (2011) 118 (21): 749.

https://doi.org/10.1182/blood.V118.21.749.749

Published: 2011

Journal Articles

Significant Recent Declines In Adult Leukemia Incidence Rates In the United States

Julie A Ross, PhD, Kimberly J Johnson, PhD, James R Cerhan, MD, PhD, Cindy K Blair, MPH, John T Soler, MPH, Phuong L. Nguyen, MD

Blood (2010) 116 (21): 873.

https://doi.org/10.1182/blood.V116.21.873.873

Published: 2010

Journal Articles

Influence of Maternal Folic Acid Supplementation on Hematopoietic Factors in Offspring.

Kimberly J. Johnson, David A. Largaespada, PhD, Tucker W. LeBien, PhD, Raha Allaei, Julie A. Ross, PhD

Blood (2007) 110 (11): 4276.

https://doi.org/10.1182/blood.V110.11.4276.4276

Published: 2007

NARROW

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Variants in PVT1 are Associated with Susceptibility for Hodgkin Lymphoma in Children and Adolescents: A Children’s Oncology Group Study

Mutant tp53 Causes a Gain of Function Increase in Sensitivity to Reactive Oxygen Species in Erythroid Precursors

Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT)

Infants with Leukemia Exhibit Compound Heterozygosity for Deleterious Germline Variation in MLL3 Independent of MLL-Rearrangements

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

KIR Gene Repertoire and Hodgkin Lymphoma In Children and Adolescents: A Children’s Oncology Group Study

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Young Paternal Age and Risk Of Infant Acute Lymphoblastic Leukemia

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Germline Exome Sequencing From MLL -Negative Infant AML Patients Reveals Compound Heterozygosity For Novel, Non-Synonymous Alleles Of MLL3 : A Report From The Children’s Oncology Group (COG)

A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33 + Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages

Comparison of IPSS and IPSS-R Scoring in a Population Based Myelodysplastic Syndromes (MDS) Study

Bi-Specific Killer Cell Engagers (BiKEs) Signaling Through CD16 and Targeting CD33 (CD16 × CD33), Triggers Natural Killer (NK) Cell Cytotoxic and Cytokine Production Against Refractory Acute Myeloid Leukemia (AML)

Matched Exome Sequencing in Mothers and Infants with MLL-Negative Acute Leukemia

Initial Clinical Findings From a Population-Based Study of Adult Myelodysplastic Syndrome: Discordance Between World Health Organization (WHO) Classifications

Genetic Susceptibility Loci and Risk of Infant Leukemia by Subtype and MLL status: A Children's Oncology Group Report

Significant Recent Declines In Adult Leukemia Incidence Rates In the United States

Influence of Maternal Folic Acid Supplementation on Hematopoietic Factors in Offspring.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only